callIcon

Dr. Sathish Arjunan

Consultant & Head

MBBS, MDRT, DNB(RT)

Educational Qualifications:

  • MBBS (2006-2012) Tanjore Medical College
  • MDRT (2015 – 2018) Kidwai Cancer Institute, Bangalore
  • DNB (RT) 2020, NAT Board, New Delhi

Work Experience:

  • 2024 — Present, Consultant & Head in Radiation Oncology at Sringeri Sharada Equitas Hospital
  • 2023 – 2024 – Consultant, Rela Institute & Medical Sciences
  • 2022 – 2023, Associate Consultant, Rela Institute & Medical Sciences
  • 2019 – 2022, Senior Registrar, Apollo Cancer Institute, Teynampet
  • 2018 – 2019, Junior Consultant, Ashwin Cancer Care, Coimbatore

Training Course:

  • Cadaveric brachytherapy hands on workshop in head and neck cancers held at M.S. Ramaiah Medical College, Bangalore, february 2020.

Work Expertise

  • 6 years in Evaluation, Planning, and Treatment of various malignancies and the management of oncological emergencies and palliative care.
  • 2D RADIOTHERAPY PLANNING
  • 3D CONFORMAL RADIOTHERAPY (3DCRT)
  • INTENSITY-MODULATED RADIOTHERAPY (IMRT)
  • IMAGE GUIDED RADIOTHERAPY (IGRT)
  • VOLUMETRIC MODULATED RADIOTHERAPY (VMAT)
  • STEREOTACTIC BODY RADIOTHERAPY (SBRT)
  • STEREOTACTIC RADIOSURGERY (SRS)
  • CYBERKNIFE
  • BRACHYTHERAPY: ICBT, ISBT, ILBT of various sites, including carcinoma cervix, head and neck carcinoma, carcinoma endometrium, carcinoma oesophagus, and carcinoma breast.

Publications

  • Naveen T, Khaleel I, Kashyap L, Goyal S, Govardhan HB, Sridhar P, Pramod KPR, Sarkar N, Sathish A. Patterns of failure in cases of carcinoma of the oesophagus treated with radical concurrent chemoradiation. Int J Med Res Rev 2016;4(5):747-750. doi: 10.17511/ijmrr.2016.i05.14.
  • A. Satish, H.B. Govardhan, T. Naveen, Siddana R. Palled, Ibrahim Khaleel, P. Sridar, L. Nabiza Begum, and Nivedita Sarkar. Effect of conventional fractionation versus hypofractionation on pulmonary function test in carcinoma of the breast. Breast J Can Res Ther 2016;12, Suppl S2:3-13

Field of Interest

  • Head and neck carcinoma, Brachytherapy, Gynaecological, Gastrointestinal, and breast carcinomas.